Biology of tissue inhibitor of metalloproteinase 3 (TIMP3), and its therapeutic implications in cardiovascular pathology

D Fan, Z Kassiri - Frontiers in Physiology, 2020 - frontiersin.org
Tissue inhibitor of metalloproteinase 3 (TIMP3) is unique among the four TIMPs due to its
extracellular matrix (ECM)-binding property and broad range of inhibitory substrates that …

Targeting dysregulation of metalloproteinase activity in osteoarthritis

K Yamamoto, D Wilkinson, G Bou-Gharios - Calcified Tissue International, 2021 - Springer
Metalloproteinases were first identified as collagen cleaving enzymes and are now
appreciated to play important roles in a wide variety of biological processes. The aberrant …

Targeting aggrecanases for Osteoarthritis Therapy: from zinc chelation to Exosite Inhibition

D Cuffaro, L Ciccone, A Rossello, E Nuti… - Journal of medicinal …, 2022 - ACS Publications
Osteoarthritis (OA) is the most common degenerative joint disease. In 1999, two members of
the A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) family of …

Engineering metalloproteinase inhibitors: tissue inhibitors of metalloproteinases or antibodies, that is the question

M Kalantar, GA Hilpert, ER Mosca… - Current Opinion in …, 2024 - Elsevier
Highlights•Inhibition of metalloproteinases has great significance for developing new
therapeutics.•Engineering protein-based inhibitors of metalloproteinases provide higher …

Targeting cartilage degradation in osteoarthritis

O McClurg, R Tinson, L Troeberg - Pharmaceuticals, 2021 - mdpi.com
Osteoarthritis is a common, degenerative joint disease with significant socio-economic
impact worldwide. There are currently no disease-modifying drugs available to treat the …

[HTML][HTML] A top-down approach to uncover the hidden ligandome of low-density lipoprotein receptor-related protein 1 in cartilage

K Yamamoto, C Scavenius, MM Meschis… - Matrix Biology, 2022 - Elsevier
The low-density lipoprotein receptor-related protein 1 (LRP1) is a cell-surface receptor
ubiquitously expressed in various tissues. It plays tissue-specific roles by mediating …

A chemo-mechano-biological modeling framework for cartilage evolving in health, disease, injury, and treatment

MM Rahman, PN Watton, CP Neu, DM Pierce - Computer Methods and …, 2023 - Elsevier
Abstract Background and Objective Osteoarthritis (OA) is a pervasive and debilitating
disease, wherein degeneration of cartilage features prominently. Despite extensive …

[HTML][HTML] Dual microparticles programmed delivery system regulating stem cell-based cartilage regeneration by cartilage-specific matrix hydrogels

X Ran, Q Wang, Y Sun, Q Pan, H Chen, W Ren… - Composites Part B …, 2024 - Elsevier
Bone marrow mesenchymal stem cells (BMSCs)-based engineered cartilage usually faces
the significant challenge of endochondral ossification tendency in an ectopic environment …

Recombinant protein drugs-based intra articular drug delivery systems for osteoarthritis therapy

H Huang, Y Lin, Y Jiang, Q Yao, R Chen… - European Journal of …, 2023 - Elsevier
Osteoarthritis (OA) is the most prevalent chronic degenerative joint disease. It weakens the
motor function of patients and imposes a significant economic burden on society. The …

[HTML][HTML] Recent advances in understanding the regulation of metalloproteinases

DA Young, MJ Barter, DJ Wilkinson - F1000Research, 2019 - ncbi.nlm.nih.gov
Metalloproteinases remain important players in arthritic disease, in part because members
of this large enzymatic family, namely matrix metalloproteinase-1 (MMP-1) and MMP-13, are …